Cited 6 time in
Caveolin-2 in association with nuclear lamina controls adipocyte hypertrophy
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Choi, Moonjeong | - |
| dc.contributor.author | Kwon, Hayeong | - |
| dc.contributor.author | Pak, Yunbae | - |
| dc.date.accessioned | 2023-03-24T08:53:46Z | - |
| dc.date.available | 2023-03-24T08:53:46Z | - |
| dc.date.issued | 2023-02 | - |
| dc.identifier.issn | 0892-6638 | - |
| dc.identifier.issn | 1530-6860 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/30357 | - |
| dc.description.abstract | Here, we identify that Caveolin-2 (Cav-2), an integral membrane protein, controls adipocyte hypertrophy in association with nuclear lamina. In the hypertrophy stage of adipogenesis, pY19-Cav-2 association with lamin A/C facilitated the disengagement of CCAAT/enhancer-binding protein alpha (C/EBP alpha) and peroxisome proliferator-activated receptor gamma (PPAR gamma) from lamin A/C and repressed Cav-2 promoter at the nuclear periphery for epigenetic activation of Cav-2, and thereby promoted C/EBP alpha and PPAR gamma-induced adipocyte hypertrophy. Stable expression of Cav-2 was required and retained by phosphorylation, deubiquitination, and association with lamin A/C for the adipocyte hypertrophy. However, obese adipocytes exhibited augmented Cav-2 stability resulting from the up-regulation of lamin A/C over lamin B1, protein tyrosine phosphatase 1B (PTP1B), and nuclear deubiquitinating enzyme (DUB), Uchl5. Our findings show a novel epigenetic regulatory mechanism of adipocyte hypertrophy by Cav-2 at the nuclear periphery. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Federation of American Societies for Experimental Biology | - |
| dc.title | Caveolin-2 in association with nuclear lamina controls adipocyte hypertrophy | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1096/fj.202201028RR | - |
| dc.identifier.scopusid | 2-s2.0-85146365030 | - |
| dc.identifier.wosid | 000915960600001 | - |
| dc.identifier.bibliographicCitation | FASEB Journal, v.37, no.2 | - |
| dc.citation.title | FASEB Journal | - |
| dc.citation.volume | 37 | - |
| dc.citation.number | 2 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
| dc.relation.journalResearchArea | Life Sciences & Biomedicine - Other Topics | - |
| dc.relation.journalResearchArea | Cell Biology | - |
| dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
| dc.relation.journalWebOfScienceCategory | Biology | - |
| dc.relation.journalWebOfScienceCategory | Cell Biology | - |
| dc.subject.keywordPlus | NECROSIS-FACTOR-ALPHA | - |
| dc.subject.keywordPlus | ADIPOSE-TISSUE EXPANDABILITY | - |
| dc.subject.keywordPlus | MESSENGER-RNA EXPRESSION | - |
| dc.subject.keywordPlus | PPAR-GAMMA | - |
| dc.subject.keywordPlus | TRANSCRIPTION FACTOR | - |
| dc.subject.keywordPlus | INSULIN SENSITIVITY | - |
| dc.subject.keywordPlus | ADIPOGENESIS | - |
| dc.subject.keywordPlus | RECEPTOR | - |
| dc.subject.keywordPlus | OBESITY | - |
| dc.subject.keywordPlus | DIFFERENTIATION | - |
| dc.subject.keywordAuthor | adipocyte hypertrophy | - |
| dc.subject.keywordAuthor | C/EBPa | - |
| dc.subject.keywordAuthor | Caveolin-2 | - |
| dc.subject.keywordAuthor | lamin A/C | - |
| dc.subject.keywordAuthor | obesity | - |
| dc.subject.keywordAuthor | PPAR gamma | - |
| dc.subject.keywordAuthor | PTP1B | - |
| dc.subject.keywordAuthor | Uchl5 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
